INC: Exploring the Long-Term Outcomes of High-Dose Oral Riboflavin in Children with Riboflavin Transporter Deficiency

Oct 24, 2024 · 2m 2s
INC: Exploring the Long-Term Outcomes of High-Dose Oral Riboflavin in Children with Riboflavin Transporter Deficiency
Description

New research from the Inherited Neuropathy Consortium (INC). This summary is based on a paper published in the journal Developmental Medicine and Child Neurology on September 9, 2024, titled "Long-term...

show more
New research from the Inherited Neuropathy Consortium (INC). This summary is based on a paper published in the journal Developmental Medicine and Child Neurology on September 9, 2024, titled "Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations." 

Read the paper here: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16083

Learn more about INC: https://inc.rarediseasesnetwork.org
show less
Information
Author RDCRN
Organization RDCRN
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search